Biomarin Pharmaceutical Inc. (BM8)
FSX
Closed
Aug 24, 2026
Day's Range
56.6652 wk Range
42.62Overview - BM8 - Biomarin Pharmaceutical Inc.
Key Statistics
Valuation
Enterprise Value
12.42B
P/E (Trailing)
‪180.43‬
P/E (Forward)
‪62.76‬
PEG Ratio
‪-2.21‬
Price / Sales (TTM)
‪3.28‬
Price / Book
‪2.06‬
EV / EBITDA
‪22.47‬
Profitability
Gross Margin
‪79.50%‬
Profit Margin
‪2.14%‬
Operating Margin
‪21.16%‬
Return on Assets
‪3.25%‬
Return on Equity
‪1.18%‬
Ownership
Shares Outstanding
193.28M
Float
192.39M
Held by Insiders
‪0.34%‬
Held by Institutions
‪103.75%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪52.67‬
200-Day Avg
‪49.22‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BM8 - Biomarin Pharmaceutical Inc.
Peers - BM8 - Biomarin Pharmaceutical Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- BM8FSXBiomarin Pharmaceutical Inc.11.17BMarket Cap+12.88%52-week change180.44P/E (Trailing)‪2.14%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - BM8 - Biomarin Pharmaceutical Inc.
About
BioMarin Pharmaceutical Inc. is a leading global biotechnology company specializing in the development and commercialization of therapies for people with serious and life-threatening rare genetic diseases. Its portfolio includes eight approved treatments targeting conditions such as mucopolysaccharidosis types I, IVA,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
